About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,341 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,341 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 481-500 of 3,341 trials

CompletedVaccine Therapy in Treating Patients With Refractory Metastatic MelanomaRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00020397·Bethesda, Maryland CompletedCALM: Managing Distress in Malignant Brain CancerThe purpose of this study is to test an empirically supported psychotherapeutic intervention, Managing Cancer and Living Meaningfully (CALM), compared to treatment as usual (TAU)…NCT06180460·Richmond, Virginia TerminatedRTX-224 Monotherapy in Patients With Solid TumorsThis is an open-label, multidose, first-in-human (FIH), Phase 1/2 study of RTX-224 for the treatment of patients with relapsed or refractory (R/R), or locally advanced solid…NCT05219578·Scottsdale, Arizona and 4 others CompletedVaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant MelanomaThis randomized pilot clinical trial studies vaccine therapy and sargramostim in treating patients with stage IV malignant melanoma.NCT00006243·Rochester, Minnesota

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedPilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV MelanomaThis is an ongoing, Phase 1, open-label, multicenter, pilot study of the checkpoint antibodies ipilimumab and nivolumab in combination with radiotherapy (RT) in 18 subjects with…NCT02659540·Stanford, California and 1 other

TerminatedFotemustine in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy, such as fotemustine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00560118·Montpellier

Active not recruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVThis phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that may have spread from where it first started to nearby tissue…NCT04514484·Chicago, Illinois and 2 others

CompletedHealth Behaviors, Surveillance, Psychosocial Factors, and Family ConcernsThe purpose of this study is to examine the health behaviors of melanoma survivors. We want to know about their thoughts and concerns.NCT00518050·New York, New York

RecruitingEvaluation of Skin Tests in Biotherapy AllergiesBiotherapies are biological (extracted from an organism or living tissue) or biotechnological drugs used in the treatment of multiple conditions, such as autoimmune inflammatory…NCT06971848·Angers

TerminatedAxitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by SurgeryThis phase II trial studies how well axitinib works in treating patients with melanoma that has spread to other places in the body or cannot be removed by surgery.NCT01533948·Buffalo, New York

TerminatedSafety Study of MGD009 in B7-H3-expressing TumorsThe purpose of this study is to evaluate the safety of MGD009 when given to patients with B7-H3-expressing tumors.NCT02628535·Los Angeles, California and 19 others

TerminatedBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesThis phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain…NCT04789668·Houston, Texas

RecruitingNeo-adjuvant Immunotherapy in Patients With Localized MelanomaThe success of anti-PD-1 and anti-CTLA-4 therapies has initiated a paradigm shift in oncology, with drugs now targeting the immune system rather than cancer cells to stimulate the…NCT07230613·Bordeaux and 5 others

TerminatedFR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant MelanomaRATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00104884

CompletedImaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its PrecursorsProspective, unicentric study that examines if imaging devices like total body photography, dermoscopy, optical coherence tomography and in vivo reflectance confocal microscopy as…NCT05842421·Dresden, Saxony

CompletedUsing Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient CareThis study aims to determine if an artificial intelligence (AI) medical device can help doctors more accurately identify a wide variety of skin conditions and improve the…NCT07428954·Bilbao, Basque Country

CompletedPyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003802·Baltimore, Maryland

CompletedTemozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaRATIONALE: Drugs used in chemotherapy, such as temozolomide and lomustine, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00072345·New York, New York

TerminatedSafety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose IpilimumaPatients with unresectable or metastatic BRAF-mutant melanoma high-risk patients will be given 450 mg orally (PO) daily (QD) plus binimetinib 45 mg PO twice daily (BID) together…NCT04655157·Pittsburgh, Pennsylvania

TerminatedMoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for MelanomaThis trial studies how well MoleMapper, Visiomed, and confocal microscopy work in screening participants for melanoma.NCT03699995·Portland, Oregon

PreviousPage 25 of 168Next